Toward optimal therapy for inhibitors in hemophilia.
Identification of a new dysfunctional platelet P2Y12 receptor variant, associated with bleeding diathesis.
Perspective: The fix is in.
Comparison of anti-xa and dilute russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxaban.
Perioperative management of two cases of hemophilia with spontaneous intracerebral hemorrhage undergoing emergency craniotomy in resource constrained setup of Nepal.
Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels.
This page was last updated September 8, 2010 and is maintained by Betsy Wilson
Vanderbilt University is committed to principles of equal opportunity and affirmative action. Copyright 2014 © Vanderbilt University Medical Center.